The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Hi folks,
It’s been a while since I came on here. Despite investing in April last year, the quality of reasonable opinion diminished reasonably quickly. Special thanks to the honest commentary of BBN, Myles, Ophidian and Rich in particular. I follow them on Twitter now than paying much attention to what is exchanged in here.
In the interests of transparency, here are my honest thoughts:
- I was first attracted to Avacta following Alistairs interview on Sky News. ‘We are bringing a best in class antigen test to the market.’ This brought the company to my attention and I have conducted my own fundamental analysis. I still regard Avacta as a LONG TERM HOLD. Even more so now as the fundamentals have improved. We are generating multi millions more than we were then.
- Like many, I am frustrated by the manner of public communication. The placing, housegait a few days before vaccine news and then the strategic pivot 31 days after stinks.
- Avacta failed to deliver in its quest to deliver a saliva based antigen LFT in the summer. Period.
- The opportunity for Avacta to accrue immense revenue via COVID market remains. The market is astronomical and the journey towards regular, global asymtomatic testing is just beginning. Avacta doesn’t have to erase Covid to become a hugely rewarding investment. It needs to sell lots of products. These products are in the development phase and the market will exist, probably for at least a few decades.
- Investor sentiment is dwindling but that’s short termism. I bought all the way up to 180p and I don’t be selling anything irrespective of what happens re: Covid. I have invested an amount I don’t need to touch to live my current lifestyle and I advise you do the same. There is more to life than investing and the stresses of the pandemic need no extra fuel. Take care of yourself and your loved ones.
- time in the market is better than timing the market. I have thought many times about cashing in and chasing Bitcoin and Tesla - however Avacta are going to experience similar trajectory soon.
Take care and stay safe.
Yes
https://post.parliament.uk/the-latest-in-covid-19-testing-developing-new-technologies/
But we need a working product. You can’t tender for a contract without a product. As you can see, it’s a competitive market. However, there is plenty opportunity to go around.
Be patient with your investment and you’ll be fine.
- tomorrow’s announcement won’t include avacta. Our test isn’t ready yet.
- this isn’t the final time any money will be spent on Antigen tests.
- two years worth of testing indicates longevity of the market.
- avacta will accrue considerable revenues when the test is released.
- the share price will fall tomorrow. I won’t be selling but I feel it in the pit of my stomach.
- the share price will surpass previous highs.
- patient shareholders will make a few bob. Impatient investors will be replaced.
Ouch. Today was a seriously sore one for many on the stock market. However, this is all temporary and only real once you finalise a trade.
This reminds me of earlier in the year when the SP plummeted after the placing. We went from 200p to 97p like a bolt of lightening. Yes there is panic and all sorts of skullduggery from short sellers, who feed off the fear, but the fundamentals remained the same and the SP recovered.
I’m really interested to see how things go from here. I haven’t sold a share and will continue to hold. Avacta does need to get the ball rollout but I do believe we are close.
Remember - Avacta does not need to change the world. It needs to sell tests to accelerate the development of its product portfolio. In particular, the cancer treatment. The demand for tests is increasing. End of.
I suspect Avacta will enjoy a revolutionary 2021.
Good luck all.
Been invested here since April. Fantastic share with lots of long term potential - if you can be patient.
USA reporting highest daily uptick of new cases. Let’s be serious - no one company can cover an entire nation. This whole first past the post theory is redundant. Yes, there will be social media hype and sp fluctuations but any company with a reliable Covid test on the market within the next year is going to accrue considerable revenue.
I don’t use this board anymore. It’s such an expensive waste of time.
Good luck all - stay humble and wise to pathetic agendas on LSE.
Everyone has an agenda:
Those ramping want the SP to go up
Those deramping want the SP to go down (short/cheaper entry).
Facts:
- We now have two major manufacturers for our test.
- I thought the test would have been further developed by now, but there market is so vast, it’s not a first past the post who takes gold.
- Covid testing will still be a frequent practice this time next year.
Good luck all - I’ll certainly not be selling a thing.
Great day today. The just reward for holders who can see through the nonsense to realise the true value of this share.
Sky news tonight showing saliva swabbing in action at Heathrow. Great to see this being close to rollout as it will Help save millions of jobs and lives. The prospect of making a few quid off this isn’t bad either. You look at the 500% rise of SNG and can’t help but think the only instant antigen salvia test has the potential to yield seriously satisfying returns.
When the big news of optimisation and then orders drops, things will really begin to get exciting.
Good luck all and enjoy.
Great news this morning. It’s been coming and the rational members on this board could see that.
Nice to see the derampers rightly silenced.
Note of advice for newbie investors - this is why you need to trust your conviction in investing. This is particularly true for AIM, as a SP drop can bizarrely indicate positive news is just around the corner.
I expect more nonsense to be spouted between now and the launch of LFT. However, the lack of objective evidence to support opinion has been proven again today.
Congratulations to the Avacta team for their achievements this year. I can only begin to imagine how exciting it must be, to be part of this team.
Again, this is not over the line yet and there will be some bumps in the road, but it’s hard to see how the company won’t make millions in revenue from this point.
Cheers.
Global - It can drop to £1.20 if it wants. It’s elastic and changing all the time.
Those who got in very early need to stomach the wait, angst and deramping nonsense.
What I will say is, we have seen with both Sona and Sorrento that the share price will rocket like never before once good news comes. Sorrento tagging $14 in after hours trades last night.
I appreciate everyone has an agenda but there is little ambiguity that the company has the potential to be a decent earner for those of us who can see beyond the smoke and mirrors.
What really excites me is we have our infrastructure set up concurrently with LFT optimisation.
Whilst we might not be first past the post, it will come down to who can produce AND supply these en masse.
Say what you like about boohoo, they are masters in proficiency and repeatability re product manufacturing and distribution.
Shorts are out in force this morning. Ignore the noise and keep it objective.We are working with the best partner to optimise our tests - we’ve been told it works - we are compressing many key parts of the process at once (optimisation and validation).Covid going nowhere, competition yet to dominate the market.Be patient and ride it out. Otherwise you will be replaced.
DOH - I don’t think so.
The avacta LFT will sell in many millions. The test works - it has been accepted in to a major government programme and I can’t see how a company like Medusa would take such a risk in forming and hiring people, without a high probability of success via Avacta.
Always useful to take a step back and look at bigger picture than the buys and sells on any one day.
Funny old day today re: UK testing in the press and avacta share price.
Here are some brutally honest points:
- none of us have a clue about what’s going on behind closed doors. Many of us are invested due to Covid. Whether we like it or not, the immediate SP is driven by progress on LFT.
- tension in this stock is used to manipulate easily. Members on here have different agendas - some want the sp to rise, others want it to fall to gain entry, some short the stock. Nobody here owes anybody anything and wouldnt risk injury to pull you out of a fire. We are all here to make money.
- those frustrated by the timelines are naiive. The time taken to deliver a best in class product cannot be underestimated. The market is so new and so vast. It’s hard to comprehend the potential this MAY have, If delivered against.
- successful investors buy and hold with conviction. A 14% loss is nothing for experienced shareholders who underhand that share price is temporary. The wheel of fortune is always spinning in both directions.
- tomorrow morning will be brutal. The fear driven through the decline of the SP ahead of placing is valid. As a result, I suspect this to get better before this gets worse,
- if avacta releases an rns due to share price activity, it’s a sign of weakness. I don’t suspect they give too hoots about shareholders impatient. They are working on a once in a generation opportunity that requires focus, patience and humility for all concerned.
I hold and will do so until any negative news comes re: LFT failing. I have no qualms waiting for a potentially life changing investment.
Cheers
Is there any evidence to support the argument of the derampers suggesting the test has failed? I can’t see any.
This mornings news, elsewhere in the market re:care homes has put the fear in to certain people. Look at it this way, almost everyone in the world wears shoes. Is there only one shoe manufacturer globally?
The market for LFT is impossible to comprehend. It is now global focus. Of course, I am a bit frustrated that things are taking this long and there is competition in the market. However, Avacta wouldn’t have made the agreements they have re: distribution if they weren’t intending on making many millions of sales.
The dips in SP are a test of character. Nothing else. Those who can stomach and be patient will be rewarded. They always are.
- Countries adopting mandatory airport testing.
- Second wave showing its ugly face.
- lack of alternative empirical assessment to differentiate between the cold, flu and Covid.
- Autumn/winter not too far away.
It’s coming. Just be patient.